A randomised controlled trial evaluating the effect of Mindfulness-Based Stress Reduction (MBSR) on mood, quality of life and wellbeing in women with stages 0 to III breast cancer
A randomised controlled trial evaluating the effect of Mindfulness-Based Stress Reduction (MBSR) on mood, quality of life and wellbeing in women with stages 0 to III breast cancer
The aim of the study was to determine whether and to what extent mindfulness-based stress reduction (MBSR) has any effect on mood, disease related quality of life, wellbeing and endocrine symptoms in women with stages 0 to III breast cancer.
The study chiefly used a randomised controlled trial design. Eligible participants had previously attended a day centre, Breast Cancer Haven in London, which offers support, information and complementary therapies for women. Eligibility was based on ending hospital treatment for breast cancer no less than two months and no more than two years previously (N=229). Consenting participants were randomly assigned to either an immediate intervention or wait-list control group. Participants completed the Profile of Mood States (POMS) (primary outcome measure), Functional Assessment of Cancer Therapy –Breast (FACT-B) and –Endocrine (FACT-ES), including their trial outcome indices (TOI) and World Health Organisation Five-Item Wellbeing Questionnaire (WHO-5) as well as a short proforma to obtain qualitative data.
Two hundred and fourteen women, (mean age 49 years) completed the study, (a 93% response rate). Intention-to-treat between-group analysis showed that after the intervention, participants in the MBSR group, compared to controls, had statistically significantly improved scores on POMS Total Mood Disturbance at both eight weeks with MBSR group mean (SD) of 30.02 (31.60) compared to controls 47.81(39.81) (95% CI for difference -27.44 to -18.14, p<0.001) and 12 weeks mean (SD) of 29.83 (34.19) compared to controls 45.43 (35.51) (95% CI -25.01 to -6.20, p<0.001). Significant improvements were also found on all POMS subscales – anxiety, depression, anger, vigour, fatigue and confusion. Significant improvements were also found on a range of FACT dimensions: FACT-B, -ES, -B TOI, -ES TOI, and physical, emotional and functional wellbeing subscales, as well as on the WHO-5 Wellbeing Questionnaire. Qualitative findings revealed that participants found themselves to be more mindful and key themes included being calmer, centred, at peace, connected and more confident; being more aware; coping with stress, anxiety and panic; and accepting things as they are, being less judgemental of myself and others.
The generalisability of these findings will be limited to those women attending Breast Cancer Haven with stages 0 to III breast cancer.
MBSR was effective in improving mood state, quality of life including endocrine symptom and wellbeing in female breast cancer survivors (diagnosed with stages 0 to III breast cancer).
mindful, breast cancer, rct, quality of life
Hoffman, Caroline Jane
9d5c567c-ce82-4782-9c7b-c80b5676ddc0
2009
Hoffman, Caroline Jane
9d5c567c-ce82-4782-9c7b-c80b5676ddc0
Ersser, Steven
09c17777-b01e-495e-b3ad-d7e4035b88e2
Hopkinson, Jane
0d49da6d-9779-4a72-a2ce-8349186529b6
Nicholls, Peter
18255e5f-5086-4cc5-bf75-d6aad9ee51d9
Corner, Jessica
eddc9d69-aa12-4de5-8ab0-b20a6b5765fa
Hoffman, Caroline Jane
(2009)
A randomised controlled trial evaluating the effect of Mindfulness-Based Stress Reduction (MBSR) on mood, quality of life and wellbeing in women with stages 0 to III breast cancer.
University of Southampton, School of Health Sciences, Doctoral Thesis, 415pp.
Record type:
Thesis
(Doctoral)
Abstract
The aim of the study was to determine whether and to what extent mindfulness-based stress reduction (MBSR) has any effect on mood, disease related quality of life, wellbeing and endocrine symptoms in women with stages 0 to III breast cancer.
The study chiefly used a randomised controlled trial design. Eligible participants had previously attended a day centre, Breast Cancer Haven in London, which offers support, information and complementary therapies for women. Eligibility was based on ending hospital treatment for breast cancer no less than two months and no more than two years previously (N=229). Consenting participants were randomly assigned to either an immediate intervention or wait-list control group. Participants completed the Profile of Mood States (POMS) (primary outcome measure), Functional Assessment of Cancer Therapy –Breast (FACT-B) and –Endocrine (FACT-ES), including their trial outcome indices (TOI) and World Health Organisation Five-Item Wellbeing Questionnaire (WHO-5) as well as a short proforma to obtain qualitative data.
Two hundred and fourteen women, (mean age 49 years) completed the study, (a 93% response rate). Intention-to-treat between-group analysis showed that after the intervention, participants in the MBSR group, compared to controls, had statistically significantly improved scores on POMS Total Mood Disturbance at both eight weeks with MBSR group mean (SD) of 30.02 (31.60) compared to controls 47.81(39.81) (95% CI for difference -27.44 to -18.14, p<0.001) and 12 weeks mean (SD) of 29.83 (34.19) compared to controls 45.43 (35.51) (95% CI -25.01 to -6.20, p<0.001). Significant improvements were also found on all POMS subscales – anxiety, depression, anger, vigour, fatigue and confusion. Significant improvements were also found on a range of FACT dimensions: FACT-B, -ES, -B TOI, -ES TOI, and physical, emotional and functional wellbeing subscales, as well as on the WHO-5 Wellbeing Questionnaire. Qualitative findings revealed that participants found themselves to be more mindful and key themes included being calmer, centred, at peace, connected and more confident; being more aware; coping with stress, anxiety and panic; and accepting things as they are, being less judgemental of myself and others.
The generalisability of these findings will be limited to those women attending Breast Cancer Haven with stages 0 to III breast cancer.
MBSR was effective in improving mood state, quality of life including endocrine symptom and wellbeing in female breast cancer survivors (diagnosed with stages 0 to III breast cancer).
Text
Caroline_Hoffman_PhD_E-Thesis.pdf
- Version of Record
More information
Published date: 2009
Keywords:
mindful, breast cancer, rct, quality of life
Organisations:
University of Southampton
Identifiers
Local EPrints ID: 72243
URI: http://eprints.soton.ac.uk/id/eprint/72243
PURE UUID: 68391586-4cef-43e1-ad89-d2fcb053a988
Catalogue record
Date deposited: 04 Feb 2010
Last modified: 13 Mar 2024 21:22
Export record
Contributors
Author:
Caroline Jane Hoffman
Thesis advisor:
Steven Ersser
Thesis advisor:
Jane Hopkinson
Thesis advisor:
Peter Nicholls
Thesis advisor:
Jessica Corner
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics